title: Alemtuzumab for relapsing-remitting multiple sclerosis.
authors.forename: Richard A
authors.initials: RA
authors.lastname: Diaz
authors.forename: Sally
authors.initials: S
authors.lastname: Doss
authors.forename: Martyn J
authors.initials: MJ
authors.lastname: Burke
authors.forename: Elisabeth
authors.initials: E
authors.lastname: George
authors.forename: Amanda I
authors.initials: AI
authors.lastname: Adler
mesh_terms: D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000191:economics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D017723:Drug Utilization Review; D006801:Humans; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000074323:Alemtuzumab